Bluetongue virus serotype 3 in ruminants in the Netherlands: Clinical signs, seroprevalence and pathological findings

Author:

van den Brink Katrien M. J. A.1ORCID,Santman‐Berends Inge M. G. A.1,Harkema Liesbeth1,Scherpenzeel Christian G. M.1,Dijkstra Eveline1ORCID,Bisschop Petra I. H.1,Peterson Karianne1,van de Burgwal Nienke Snijders1,Waldeck Hubert W. F.1,Dijkstra Thomas1,Holwerda Melle2,Spierenburg Marcel A. H.3,van den Brom René1

Affiliation:

1. Royal GD Deventer The Netherlands

2. Wageningen Bioveterinary Research Lelystad The Netherlands

3. Dutch Food and Consumer Product Safety Authority (NVWA) Utrecht The Netherlands

Abstract

AbstractBackgroundThe bluetongue virus serotype 3 (BTV‐3) outbreak in the Netherlands in 2023 caused severe clinical signs in ruminants. The clinical and pathological signs in ruminants and their spread during the outbreak in 2023 are described.MethodsData from the Dutch monitoring and surveillance system were available to describe clinical signs and pathological findings related to BTV‐3 in sheep, cattle and goats. During the outbreak, 13 farms (five sheep, five cattle and three dairy goats) were closely monitored.ResultsIn 2023, BTV‐3 infections were confirmed by real‐time polymerase chain reaction in sheep flocks (n = 1807), cattle herds (n = 1864), goat herds (n = 62), alpaca and/or llama herds (n = 15) and one dog. Sheep exhibited the most severe clinical signs and had the highest mortality. In other animal species, a large variation in both occurrence and severity of clinical signs was observed.LimitationOnly 13 farms were closely monitored.ConclusionsThe clinical signs observed in affected animals during the 2023 BTV‐3 outbreak seem to be more severe than those observed during the BTV‐8 outbreak between 2006 and 2008. It seems likely that BTV‐3 will overwinter, similar to BTV‐8. Therefore, the availability of an effective and safe vaccine is crucial to limit the future impact of BTV‐3.

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3